Drugs / Lipiodol Ultra Fluide®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04379973 | May 2021 → Jun 2027 expected | female infertility | Dafne Balemans | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipiodol Ultra Fluide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04379973 ↗ |
| Modality | Diagnostic / imaging agent | “oil-soluble contrast medium (OSCM)” NCT04379973 ↗ |
| Route | Other | “Tubal flush with 5-10mL oil-soluble contrast medium” NCT04379973 ↗ |